13 - 19 January 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
FDA finds against vitamin D and risk of MS claim
The FDA, the American drug regulator, has turned down a request from a pharmaceutical company for permission to say that consumption of vitamin D may reduce the risk of developing MS. The decision followed a review of the published research, which concluded that there is currently "no credible evidence" to support the claim
MS Trust link: Vitamin D
Medical cannabis supported by Welsh Assembly
The Welsh Assembly has voted in favour of a motion to lobby the UK Government to make cannabis legal for medicinal use. The devolved government can't change the law itself. The articles include two people with MS talking about how cannabis has helped their symptoms
MS Trust link: Cannabis
Branded vs generic glatiramer study
MS Trust launches 'Move it For MS' exercise campaign for MS Awareness Week
25 April 2019
This MS Awareness Week, we are calling on people with MS to pop on their pumps and introduce a little activity into their daily routine. Staying active doesn’t need to mean running marathons or going to the gym, it’s about doing it at your own level, at your own pace. Doing it YOUR way.
Don’t judge a book by its cover – Becky’s books help the MS Trust
24 April 2019
Our supporter Becky is raising money for the MS Trust with the sale of her beautiful handmade notebooks.
EMA recommends temporary restriction on use of Lemtrada
12 April 2019
The European Medicines Agency has recommended a temporary restriction on people who should start treatment with Lemtrada while a review of side effects is carried out.